Obesity is a pandemic affecting the world over. Worldwide obesity has nearly tripled since 1975. In 2016, more than 1.9 billion (39%) of the world’s adults were overweight. Of these over 650 (13%) million were obese. 39 million children under the age of 5 were overweight. 340 million children aged 5-19 were overweight or obese in 2016. [World Health Organization – 2021]
Obesity results in developing the metabolic syndrome – visceral obesity, hypertension (high blood pressure), insulin resistance (leading to developing diabetes) and increased cholesterol and triglycerides. This leads to significant medical complications affecting various organ systems – such as the brain, heart, lungs liver, pancreas, and other organ systems.
The intragastric balloon is a minimally invasive device inserted directly into the stomach via an endoscope which allows for significant weight reduction. This device in conjunction with professional support via the team Dr. Coovadia has assembled with assist in significant weight reduction – resulting in improved quality of life and overall health.
Please click here to see Dr. Coovadia's comprehensive presentation on the benefits of intragastric balloon insertion for patients who qualify for the procedure.